No abstract

This study explored the removal of six pharmaceutically active compounds (PhACs) in lab-scale experiments with sediments under four redox conditions, namely aerobic, nitrate reducing, sulfate reducing, and methanogenic conditions using batch and column set-ups. Redox conditions were found to influence PhAC removal by sorption and biodegradation. The most optimal PhAC removal was observed at the outer ranges of the redox spectrum, i.e. either aerobic or deep anaerobic (sulfate reducing and methanogenic conditions), whereas nitrate reducing conditions were found least effective for PhACs biodegradation and sorption. For instance, sorption coefficient K values for metoprolol in column experiments were 90, 65, 42 and 11 L/kg for sulfate reducing, methanogenic, aerobic and nitrate reducing conditions, respectively. For the same conditions K values for propranolol were 101, 94, 55 and 55 L/kg, respectively. As expected, biodegradation efficiencies were highest under aerobic conditions, showing >99% removal of caffeine and naproxen, but no removal for propranolol and carbamazepine. The adaptive capacity of sediment was demonstrated by pre-exposure to PhACs leading to improved PhAC biodegradation. The results of this study indicate the necessity to combine diverse redox conditions, including aerobic conditions, for maximizing PhAC removal by sorption and biodegradation. Furthermore, our findings stress the need for additional treatment measures as recalcitrant PhACs are not effectively removed under any redox condition.

Individual treatment processes like biological treatment or ozonation have their limitations for the removal of pharmaceuticals from secondary clarified effluents with high organic matter concentrations (i.e. 17 mg TOC/L). These limitations can be overcome by combining these two processes for a cost-effective pharmaceutical removal. A three-step biological-ozone-biological (BOB) treatment process was therefore designed for the enhanced pharmaceutical removal from wastewater effluent. The first biological step removed 38% of ozone scavenging TOC, thus proportionally reducing the absolute ozone input for the subsequent ozonation. Complementariness between biological and ozone treatment, i.e. targeting different pharmaceuticals, resulted in cost-effective pharmaceutical removal by the overall BOB process. At a low ozone dose of 0.2 g O/g TOC and an HRT of 1.46 h in the biological reactors, the removal of 8 out of 9 pharmaceuticals exceeded 85%, except for metoprolol (60%). Testing various ozone doses and HRTs revealed that pharmaceuticals were ineffectively removed at 0.1 g O3/g TOC and an HRT of 0.3 h. At HRTs of 0.47 and 1.46 h easily and moderately biodegradable pharmaceuticals such as caffeine, gemfibrozil, ibuprofen, naproxen and sulfamethoxazole were over 95% removed by biological treatment. The biorecalcitrant carbamazepine was completely ozonated at a dose of 0.4 g O/g TOC. Ozonation products are likely biodegraded in the last biological reactor as a 17% TOC removal was found. No appreciable acute toxicity towards D. magna, P. subcapitata and V. fischeri was found after exposure to the influents and effluents of the individual BOB reactors. The BOB process is estimated to increase the yearly wastewater treatment tariff per population equivalent in the Netherlands by less than 10%. Overall, the BOB process is a cost-effective treatment process for the removal of pharmaceuticals from secondary clarified effluents.

The combination of photocatalysis and biodegradation was investigated for the removal of nine selected pharmaceuticals as a means to reduce loadings into the environment. The combined process, consisting of a resource-efficient mild photocatalysis and a subsequent biological treatment, was compared to single processes of intensive photocatalysis and biological treatment. The UV-TiO 2 based photocatalysis effectively removed atorvastatin, atenolol and fluoxetine (>80%). Biological treatment after mild photocatalytic pretreatment removed diclofenac effectively (>99%), while it persisted during the single biological treatment (<50%). Moreover, the biodegradation of atorvastatin, caffeine, gemfibrozil and ibuprofen was enhanced after mild photocatalytic pretreatment compared to biological treatment alone. The enhanced biodegradation of these pharmaceuticals appeared to be triggered by the biodegradation of photocatalytic products. Mild photocatalysis followed by biological treatment is an effective and resource-efficient combination for pharmaceutical removal that could substantially reduce the loading of pharmaceuticals into the environment. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Improved biodegradation of pharmaceuticals A. de Wilt et al.